Skip to main content
. Author manuscript; available in PMC: 2024 Feb 14.
Published in final edited form as: Circ Cardiovasc Interv. 2022 Aug 16;15(8):e012103. doi: 10.1161/CIRCINTERVENTIONS.122.012103

Figure 5. Relationship between Type 1 MI and Procedural MI vs No MI and all-cause death in the ISCHEMIA and ISCHEMIA-CKD trials.

Figure 5.

Figure 5.

Main refers to the ISCHEMIA trial. CKD refers to the ISCHEMIA-CKD trial. A) All-cause Death (Primary MI Definition); B) All-cause Death (Secondary MI Definition). Top Panel: The cumulative incidence of all-cause death was greater in patients that had a type 1 MI compared with those that did not during follow-up in both trials regardless of MI definition used. The higher risk population in the ISCHEMIA-CKD trial is illustrated by the fact that the cumulative incidence of death in patients without an MI during follow-up exceeded that observed in the ISCHEMIA population with a type 1 MI.

Bottom Panel: The cumulative incidence of all-cause death after procedural MI was greater compared with those that did not have an MI during follow-up, regardless of MI definition used. In contrast, in the ISCHEMIA trial which enrolled a lower-risk population, the cumulative incidence of all-cause death after procedural MI was similar compared with those that did not have an MI during follow-up, regardless of MI definition used.